Leica Microsystems, Inc. recalls Novocastr Liquid Mouse Monoclonal Antibody CDX2 (CDX2) is recommended for the assessment of CDX2 protein in normal and…
- Recall date
- April 5, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1877-2016
- FDA classification
- Class II
- Brand / firm
- Leica Microsystems, Inc.
- Sold / distributed
- Distributed in the following states AR, CA, CT, FL, ID, IL, IN, MT, OH, PA, TN and TX, and in Canada.
Why it was recalled
Testing of retained units indicated that Lot numbers of CDX2 indicated are not stable up to the expiry date on the product labeling.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Novocastr Liquid Mouse Monoclonal Antibody CDX2 (CDX2) is recommended for the assessment of CDX2 protein in normal and neoplastic tissues.
Get recall alerts
Free email alert whenever Leica Microsystems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Leica Microsystems, Inc.